HearingTracker

Tinnitus remains one of the most stubborn and misunderstood conditions in audiology, leaving millions in search of genuine relief from constant ringing or buzzing in the ears. Promoted as a breakthrough in the field, Lenire has entered the scene with a promise of hope for sufferers—but what does the evidence actually say?

To provide clarity for those weighing their treatment options, HearingTracker audiologist Matthew Allsop, interviewed Emily E. McMahan, AuD—one of the world’s most experienced practitioners—on the HearingTracker YouTube channel.

In this wide-ranging discussion, Dr. McMahan addresses consumer skepticism, clinical realities, and the evolving science behind bimodal neuromodulation. With direct reflections from her extensive patient base and the latest independent research, this interview explores whether Lenire is living up to its claims, and what patients can really expect.

Breaking Down Tinnitus Myths: An Exclusive Interview with Dr. Emily McMahan on Lenire Promoted as a breakthrough in the field, Lenire has entered the scene with a promise of hope for sufferers—but what does the evidence actually say?

We sent two journalists to CES 2025. Here’s HearingTracker’s coverage of all the hearing aid and related tech.
EssilorLuxottica / ELEHEAR / Xander / Ceretone Hearing

From OTC Hearing Aids to Audio and Captioning Glasses: HearingTracker's CES 2025 Highlights HearingTracker scoured CES 2025 for the latest emerging products and technologies in hearing aids and hearing accessibility. Here's what we found.